$3.57
-0.33-8.46%
Last update: Nov 10, 4:00 PM
Kyntra Bio Inc
KYNBNASDAQ
The average analyst price target for Kyntra Bio is $36.80, 881.3% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $30 to $43. The latest change came on Oct 13, 2026, when Maxim Group initiated coverage of Kyntra Bio with a Buy rating and a $35 price target.
Price Target Range — 3 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
